Document Detail


Difficult asthma.
MedLine Citation:
PMID:  16493159     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The correct diagnosis of asthma is usually easily made and most patients with asthma respond to therapy. Approximately 5% of patients with asthma, however, have disease that is difficult to control despite taking maximal doses of inhaled medications. Patients with therapy-resistant or difficult-to-control asthma require a rigorous and systematic approach to their diagnosis and treatment. The first step is evaluation and testing directed at determining that asthma is the correct diagnosis. Many diseases mimic asthma and these alternate diagnoses should be considered. The second step is to identify and eliminate triggers that worsen asthma. Cigarette smoking, occupational exposures, and allergic rhinitis contribute to worsening disease. Most patients with "difficult asthma" require treatment with high-dose inhaled corticosteroids and long-acting inhaled beta(2)-agonists. Despite maximal inhaled therapy, these patients will require either frequent bursts or chronic daily therapy with oral corticosteroids. These patients may have "resistant" inflammation with a persistent inflammatory state. Numerous studies also suggest that compliance with asthma therapy is poor. Combination therapy with inhaled corticosteroids and long-acting beta(2)-agonist in a single inhaler may improve patient compliance. In selected patients, additional therapy with leukotriene modifiers or anti-IgE antibody can result in improved asthma control and may allow tapering of corticosteroids. Use of methotrexate is not justified based on current data. Emerging evidence suggests that different phenotypes of difficult or therapy-resistant asthma exist. Recognition of these subgroups allows tailored therapy and prevents overmedication in an attempt to normalize lung function in patients with irreversible airflow obstruction.
Authors:
Mary E Strek
Related Documents :
2806509 - Energy expenditure and rib cage-abdominal motion in chronic obstructive pulmonary disease.
21054669 - Laryngeal penetration and aspiration in individuals with stable copd.
3445879 - Airway hyperreactivity and menstrual cycle in asthmatic patients.
22461829 - Osteoporosis in patients with subclinical hypothyroidism treated with thyroid hormone.
22492869 - A tshr-lh/cgr chimera that measures functional thyroid-stimulating autoantibodies (tsab...
1691649 - Airway complications in charge association.
9116979 - Pulmonary involvement in fabry disease.
7351679 - Diagnosis of acute abdominal injuries in patients with spinal shock: value of diagnosti...
9146479 - Somatosensory evoked potentials in adults with cortical dysgenesis and epilepsy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Proceedings of the American Thoracic Society     Volume:  3     ISSN:  1546-3222     ISO Abbreviation:  Proc Am Thorac Soc     Publication Date:  2006  
Date Detail:
Created Date:  2006-02-22     Completed Date:  2006-07-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  101203596     Medline TA:  Proc Am Thorac Soc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  116-23     Citation Subset:  IM    
Affiliation:
Section of Pulmonary and Critical Care Medicine, Department of Medicine, Committee on Clinical Pharmacology and Pharmacogenetics, University of Chicago, Chicago, Illinois 60637, USA. mstrek@medicine.bsd.uchicago.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Asthma* / classification,  diagnosis,  drug therapy
Bronchodilator Agents / therapeutic use
Diagnosis, Differential
Glucocorticoids / therapeutic use
Humans
Prognosis
Severity of Illness Index
Chemical
Reg. No./Substance:
0/Bronchodilator Agents; 0/Glucocorticoids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary arterial hypertension.
Next Document:  Sleep apnea.